MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects.

Pseudomonas aeruginosa (Pa) is the most common virulent pathogen contributing to the pathogenesis of cystic fibrosis (CF). During bacterial lung colonization, the products of its metabolism are released in the extracellular space contributing to the pathogenic events associated with its presence. To gain insights on the mechanisms involved in the Pa pathogenesis we focused our attention on proteins released by Pa using a MudPIT approach combined with cell biology assays. Conditioned medium (CM) collected under aerobic and microaerobic conditions from Pa clinical strains (in early and late colonization), unlike the laboratory strain, induced expression of IL-8 mRNA in CF airway epithelial cells. We have identified proteins released by clinically relevant Pa strains, focusing on the pro-inflammatory effects as metalloproteases (MMPs). In fact, their expression pattern was associated with the highest pro-inflammatory activity measured in the early clinically isolated strain. The relation was further supported by the result of the analysis of a larger and independent set of Pa isolates derived from sporadically and chronically infected CF patients: 76% of sporadic samples expressed protease activity (n = 44), while only 27% scored positive in the chronically infected individuals (n = 38, p < 0.0001, Fisher's exact test). Finally, looking for a possible mechanism of action of bacterial MMPs, we found that CM from early clinical isolates can cleave CXCR1 on the surface of human neutrophils, suggesting a potential role for the bacterially released MMPs in the protection of the pathogen from the host's response.

[1]  G. Michel,et al.  Transcriptome and secretome analyses of the adaptive response of Pseudomonas aeruginosa to suboptimal growth temperature. , 2009, International Microbiology.

[2]  J. Buer,et al.  Expression Analysis of a Highly Adherent and Cytotoxic Small Colony Variant of Pseudomonas aeruginosa Isolated from a Lung of a Patient with Cystic Fibrosis , 2004, Journal of bacteriology.

[3]  A. Aitken,et al.  A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. , 2002, European journal of biochemistry.

[4]  M. Berger,et al.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. , 1990, The Journal of clinical investigation.

[5]  Anil K. Jain,et al.  Data clustering: a review , 1999, CSUR.

[6]  B. Tümmler,et al.  Lung function and inflammation during murine Pseudomonas aeruginosa airway infection. , 2011, Immunobiology.

[7]  F. Duong,et al.  Sequence of a cluster of genes controlling synthesis and secretion of alkaline protease in Pseudomonas aeruginosa: relationships to other secretory pathways. , 1992, Gene.

[8]  M. Horwitz,et al.  High Extracellular Levels of Mycobacterium tuberculosis Glutamine Synthetase and Superoxide Dismutase in Actively Growing Cultures Are Due to High Expression and Extracellular Stability Rather than to a Protein-Specific Export Mechanism , 2001, Infection and Immunity.

[9]  A. Prince,et al.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.

[10]  F. Rossi,et al.  Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. , 1986, Biochemical and biophysical research communications.

[11]  Anna L Jansson,et al.  Delineation of exoenzyme S residues that mediate the interaction with 14‐3‐3 and its biological activity , 2006, The FEBS journal.

[12]  A. Wullaert,et al.  The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1β maturation , 2007, Journal of cellular and molecular medicine.

[13]  Pierluigi Mauri,et al.  A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli. , 2008, Methods in enzymology.

[14]  Edward M. Marcotte,et al.  Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations In Vivo , 2010, mBio.

[15]  A. G. Day,et al.  The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase. , 2004, The Biochemical journal.

[16]  Ruedi Aebersold,et al.  The Need for Guidelines in Publication of Peptide and Protein Identification Data , 2004, Molecular & Cellular Proteomics.

[17]  K. Botzenhart,et al.  Extracellular toxins of Pseudomonas aeruginosa. III. Radioimmunoassay for detection of alkaline protease. , 1982, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[18]  C. Di Serio,et al.  Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. , 2009, American journal of respiratory and critical care medicine.

[19]  Y. Higashimoto,et al.  A novel secreted protease from Pseudomonas aeruginosa activates NF‐κB through protease‐activated receptors , 2008, Cellular microbiology.

[20]  S. Rose-John,et al.  Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor , 1996, Infection and immunity.

[21]  C. Mody,et al.  Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S , 2002, Journal of leukocyte biology.

[22]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[23]  I. Brockhausen,et al.  Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. , 1997, Behring Institute Mitteilungen.

[24]  A. Scarpa,et al.  Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  U. Romling,et al.  Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment , 2005, Proteomics.

[26]  J. Klockgether,et al.  Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. , 2006, Microbiology.

[27]  J. Mattick,et al.  Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. , 2003, Microbiology.

[28]  V. Deretic,et al.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. , 1996, Microbiological reviews.

[29]  Ruedi Aebersold,et al.  High throughput protein characterization by automated reverse‐phase chromatography/electrospray tandem mass spectrometry , 1998, Protein science : a publication of the Protein Society.

[30]  C. Rudolph,et al.  Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease , 2007, Nature Medicine.

[31]  B. Assael,et al.  Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. , 2006, Biochemical and biophysical research communications.

[32]  A J Ratner,et al.  Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. , 2000, American journal of respiratory cell and molecular biology.

[33]  George Karypis,et al.  Data clustering in life sciences , 2005, Molecular biotechnology.

[34]  M. Hodson,et al.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. , 2000, The European respiratory journal.

[35]  M. Thomassen,et al.  Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition , 1985, Infection and immunity.

[36]  A. Azghani,et al.  A bacterial protease perturbs the paracellular barrier function of transporting epithelial monolayers in culture , 1993, Infection and immunity.

[37]  D. Dearborn,et al.  Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. , 1989, The Journal of clinical investigation.

[38]  Simone Daminelli,et al.  Extraction methods of red blood cell membrane proteins for Multidimensional Protein Identification Technology (MudPIT) analysis. , 2010, Journal of chromatography. A.

[39]  David A. D'Argenio,et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Guanghui Wang,et al.  Decoy methods for assessing false positives and false discovery rates in shotgun proteomics. , 2009, Analytical chemistry.

[41]  D. P. Speert,et al.  Genetic Adaptation of Pseudomonas aeruginosa to the Airways of Cystic Fibrosis Patients Is Catalyzed by Hypermutation , 2008, Journal of bacteriology.

[42]  J. Wehland,et al.  Inter- and Intraclonal Diversity of the Pseudomonas aeruginosa Proteome Manifests within the Secretome , 2003, Journal of bacteriology.

[43]  João C Setubal,et al.  Protein secretion systems in bacterial-host associations, and their description in the Gene Ontology , 2009, BMC Microbiology.

[44]  F. Rossi,et al.  Polynucleotide phosphorylase hinders mRNA degradation upon ribosomal protein S1 overexpression in Escherichia coli. , 2008, RNA.

[45]  J. Costerton,et al.  Influence of culture conditions on expression of the mucoid mode of growth of Pseudomonas aeruginosa , 1984, Journal of clinical microbiology.

[46]  M. Kosorok,et al.  Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.

[47]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.